Interview with the CEO: GeNeuro SA (OTCMKTS:GNRRF)

Healthcare >> CEO Interviews >> March 18, 2022

Jesús Martin-Garcia is the Chief Executive Officer of GeNeuro SA. Mr. Martin-Garcia began his career in 1983 at the World Economic Foundation, and in 1989 at McKinsey & Co. where he led studies in the pharmaceutical and food industries. By 1993, he chose the entrepreneurial path by creating, investing and leading start-ups in Switzerland and the United States. He was, for example, a co-founder of LeShop in 1996, which became the Swiss leader in e-commerce and was sold to Migros. In 2003, he created Eclosion, a public-private partnership for translating scientific discoveries in the field of life sciences into innovative drugs with disruptive potential. This unique structure was instrumental in the creation of GeNeuro, which was led by Mr. Martin-Garcia since its creation in 2006. Mr. Martin-Garcia holds a bachelor’s degree in industrial sciences, a master in law from Geneva University and an MBA from Harvard Business School. He serves on the board of several biotech companies and industrial and business associations. Profile

Word count: 3,762

TWST: Can you start with giving me an overview of the company, its origins and its mission?

Mr. Martin-Garcia: GeNeuro is a spin-off of

Join for free to read a longer excerpt or purchase this article

Interview with the CEO: GeNeuro SA (OTCMKTS:GNRRF)

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS

Interview with the CEO: GeNeuro SA (OTCMKTS:GNRRF)

Top Company Interviews

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS